Skip to main content
letter
. 2020 May 22;117(21):373–374. doi: 10.3238/arztebl.2020.0373

Table 1. Pre-existing illnesses. treatments. and outcome of children and adolescents with COVID-19 admitted to hospital in Germany*.

Existing illnesses n (%)
Total
Pulmonary
Cardiac
Neurological/neuromuscular
Hematological/oncological
Congenital immune defect
Autoimmune disease
Pharmacological immunosuppression
Diabetes mellitus
Other
26 (26)
15 (15)
8 (8)
5 (5)
4 (4)
1 (1)
2 (2)
6 (6)
3 (3)
15 (15)
Treatments n (%)
Oxygen supplementation
Non-invasive ventilation
Invasive ventilation
NO inhalation
Tracheostomy
Inotropics/vasopressors
Inhalation with bronchodilators
Systemic steroids
Antibiotic tteatment
Antiviral treatment for SARS-CoV-2
Non-steroidal antirheumatic (NSAR)
Renal replacement therapy
16 (16)
7 (7)
5 (5)
2 (2)
2 (2)
5 (5)
17 (17)
9 (9)
36 (36)
1 (1)
22 (22)
2 (2)
Outcome n (%)
Complete recovery
Mild residual symptoms
Death
75 (75)
24 (24)
1 (1)

* The percentages relate to patients already discharged from the hospital (n = 100).

Multiple answers possible